Novarel¿ (chorionic Gonadotropin recalls

The FDA has published 1 recall involving Novarel¿ (chorionic Gonadotropin since 2012. The latest was reported on 12 Dec 2012. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Dec 2012

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why novarel¿ (chorionic gonadotropin is recalled

Packaging Defects1100%

Companies

Ferring Pharmaceuticals1100%

By year

20121100%

All novarel¿ (chorionic gonadotropin recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
12 Dec 2012Drug	CLASS III	Novarel¿ (Chorionic Gonadotropin for injection, USP) recalled	Ferring Pharmaceuticals	Packaging Defects	Nationwide

Should you stop taking Novarel¿ (chorionic Gonadotropin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.